Daunorubicin and Its Active Metabolite Pharmacokinetic Profiles in Acute Myeloid Leukaemia Patients: A Pharmacokinetic Ancillary Study of the BIG-1 Trial.

Saved in:
Bibliographic Details
Title: Daunorubicin and Its Active Metabolite Pharmacokinetic Profiles in Acute Myeloid Leukaemia Patients: A Pharmacokinetic Ancillary Study of the BIG-1 Trial.
Authors: Drevin, Guillaume1,2 (AUTHOR) alschmidt@chu-angers.fr, Briet, Marie1,2,3 (AUTHOR) marie.briet@chu-angers.fr, Bazzoli, Caroline4 (AUTHOR) caroline.bazzoli@univ-grenoble-alpes.fr, Gyan, Emmanuel5,6 (AUTHOR) corentin.orvain@chu-angers.fr, Schmidt, Aline2,6,7,8 (AUTHOR) aurelien.giltat@chu-angers.fr, Dombret, Hervé9 (AUTHOR) herve.dombret@aphp.fr, Orvain, Corentin6,7 (AUTHOR), Giltat, Aurelien6,7 (AUTHOR), Recher, Christian10 (AUTHOR) recher.christian@iuct-oncopole.fr, Ifrah, Norbert2,6,7 (AUTHOR) mahunault@chu-angers.fr, Guardiola, Philippe2 (AUTHOR), Hunault-Berger, Mathilde2,6,7,8 (AUTHOR), Abbara, Chadi1 (AUTHOR) chadi.abbara@chu-angers.fr
Source: Pharmaceutics. Apr2022, Vol. 14 Issue 4, pN.PAG-N.PAG. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19994923
DOI:10.3390/pharmaceutics14040792